...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What Monday Brings?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Kayaker I may have just sent you three or more messages, or none at all. But basically thank-you. That was what I was trying to say.

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply